🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with heart failure hospitalization reduction on semaglutide? Page 3

Has anyone dealt with heart failure hospitalization reduction on semaglutide?

KetoKyle Tue, Feb 24, 2026 at 9:52 AM 30 replies 1,463 viewsPage 3 of 6
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Mar 1, 2026 at 7:21 AM#11
paige_pharma said:
Steady state is the thing most people miss.

That holds for the injectable. The oral formulation has different absorption behaviour and the dose numbers are not interchangeable, which is worth saying out loud because people quote them as if they were.

Correct me if the detail matters more than I have assumed.

Last edited: Mar 1, 2026 at 10:21 AM
47 22steve_okc, dave_SLC, FDA_TrackerJim and 44 others
Reply Quote Save Share Report
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Mar 1, 2026 at 12:35 PM#12
FDA_TrackerJim said:
All true, with one condition: that curve is for people who reached the dose on schedule.

Thank you for spelling out the reasoning rather than just the conclusion. Adding it to my notes with a link back to this thread.

46 21alex_tucson, kevin_tulsa, Dr.PainCLE and 43 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Mar 1, 2026 at 5:49 PM#13
paige_pharma said:
Steady state is the thing most people miss.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

Correct me if the detail matters more than I have assumed.

45 20robert_kc, dan_philly, MeganSA_TX and 42 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Mar 1, 2026 at 11:03 PM#14
KetoKyle said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

Last edited: Mar 2, 2026 at 3:03 AM
44 19JessicaM_2024, TomFromTexas, mike.trainer_LA and 41 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 2, 2026 at 4:17 AM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Thread quality here is what the rules are for. Keep it up.

43 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 40 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register